Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Cephalalgia : an International Journal of Headache
|
March 26, 2014
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E Bigal, Sarah Walter, Michele Bronson, et al.
Advances in Simulation (London, England)
|
August 1, 2020
SAFEE: A Debriefing Tool to Identify Latent Conditions in Simulation-based Hospital Design Testing
Nora Colman, Ashley Dalpiaz, Sarah Walter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Sarah Walter, Lauren Ptomey, Ann D Cohen, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2022
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?
Sarah Walter, Anne B Kim, Melissa Flores, et al.
Nature Reviews. Neurology
|
April 5, 2022
Early-stage Alzheimer disease: getting trial-ready
Paul S Aisen, Gustavo A Jimenez-Maggiora, Michael S Rafii, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
January 24, 2022
The nutritional impact of a feeding protocol for infants on high flow nasal cannula therapy
Sarah Walter, Stephanie DeLeon, Jonathan P Walther, et al.
HERD
|
May 6, 2020
Designing for Patient Safety and Efficiency: Simulation-Based Hospital Design Testing
Nora Colman, Mary Bond Edmond, Ashley Dalpiaz, et al.
Current Alzheimer Research
|
April 18, 2017
Optimizing ADAS-Cog Worksheets: A Survey of Clinical Trial Rater s' Perceptions
Stephen M Meyer, Kristina A Bertzos, Magdalena Perez, et al.
Cephalalgia : an International Journal of Headache
|
December 25, 2013
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E Bigal, Rafael Escandon, Michele Bronson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 30, 2011
Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats
Yoshihiro Miyaji, Sarah Walter, Leon Chen, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Cephalalgia : an International Journal of Headache
|
March 26, 2014
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E Bigal, Sarah Walter, Michele Bronson, et al.
Advances in Simulation (London, England)
|
August 1, 2020
SAFEE: A Debriefing Tool to Identify Latent Conditions in Simulation-based Hospital Design Testing
Nora Colman, Ashley Dalpiaz, Sarah Walter, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Sarah Walter, Lauren Ptomey, Ann D Cohen, et al.
Journal of Alzheimer'S Disease : JAD
|
June 20, 2022
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?
Sarah Walter, Anne B Kim, Melissa Flores, et al.
Nature Reviews. Neurology
|
April 5, 2022
Early-stage Alzheimer disease: getting trial-ready
Paul S Aisen, Gustavo A Jimenez-Maggiora, Michael S Rafii, et al.
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|
January 24, 2022
The nutritional impact of a feeding protocol for infants on high flow nasal cannula therapy
Sarah Walter, Stephanie DeLeon, Jonathan P Walther, et al.
HERD
|
May 6, 2020
Designing for Patient Safety and Efficiency: Simulation-Based Hospital Design Testing
Nora Colman, Mary Bond Edmond, Ashley Dalpiaz, et al.
Current Alzheimer Research
|
April 18, 2017
Optimizing ADAS-Cog Worksheets: A Survey of Clinical Trial Rater s' Perceptions
Stephen M Meyer, Kristina A Bertzos, Magdalena Perez, et al.
Cephalalgia : an International Journal of Headache
|
December 25, 2013
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E Bigal, Rafael Escandon, Michele Bronson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 30, 2011
Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats
Yoshihiro Miyaji, Sarah Walter, Leon Chen, et al.
Page
of 6